In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Vaisala Corporation Financial Statement Release February 18, 2025, at 9:00 a.m. (EET) This release is a summary of Vaisala's Financial Statement Release January-December 2024. The complete report is ...

Apple’s ambitions in the immersive world of augmented and virtual reality (AR and VR) are off to a rough start. The $3,500 Vision Pro ...

Agile coaching is more than methods or team-level guidance, it’s a philosophy that spans the entire organization, including ...

In Q4 2024, the Frontier Emerging Markets Equity composite fell 4.1% (gross), outperforming its benchmark Index. Click here ...

For Q4 2024, the Harding Loevner International Equit composite fell 8.6% (gross) behind the 7.5% decline of the MSCI ACWI ex ...

This release is a summary of Vaisala's Financial Statement Release January-December 2024. The complete report is attached to ...

The goal of conducting a fast-tracked nuclear test can only be political, not scientific. The United States has much to lose ...

Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025.